Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 17/20 | 0.45 |
| ▸ | SLC5A1 | P13866 | 3/20 | 0.36 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.35 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.35 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.35 |
| ▸ | CDK1 | P06493 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29844391 | 1.00 | SLC5A2 (0.45) | SLC5A2SLC5A1LGALS9LGALS1LGALS7; LGALS7B | |
| SCHEMBL27551018 | 0.89 | SLC5A2 (0.45) | SLC5A2SLC5A1 | |
| SCHEMBL15814653 | 0.89 | SLC5A2 (0.43) | SLC5A2SLC5A1 | |
| SCHEMBL15814199 | 0.89 | SLC5A2 (0.43) | SLC5A2SLC5A1 | |
| SCHEMBL7680986 | 0.89 | SLC5A2 (0.43) | SLC5A2SLC5A1LGALS9LGALS1LGALS7; LGALS7B | |
| SCHEMBL7087673 | 0.89 | SLC5A2 (0.40) | SLC5A2SLC5A1 | |
| SCHEMBL28774531 | 0.85 | SLC5A2 (0.40) | SLC5A2SLC5A1LGALS9LGALS1 | |
| SCHEMBL7123688 | 0.85 | SLC5A2 (0.44) | SLC5A2SLC5A1LGALS9LGALS1LGALS7; LGALS7B | |
| SCHEMBL7199793 | 0.82 | ACHE (0.44) | SLC5A2SLC5A1 | |
| SCHEMBL7122921 | 0.82 | SLC5A2 (0.43) | SLC5A2SLC5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117511034-A | Wear-resistant weather-resistant winding core pipe and preparation method thereof | 东莞市德永塑胶制品有限公司 | 2024-02-06 | — | — | CN | claimed |
| CN-104817830-B | A kind of aromatic polyester microcellular foam material and preparation method thereof | 北京化工大学 | 2016-08-24 | — | — | CN | claimed |
| US-9421266-B2 | Safety of pseudoephedrine drug products | PISGAH LABORATORIES, INC. (US) | 2016-08-23 | — | — | US | claimed |
| CN-104817830-A | Aromatic polyester foaming microcellular foaming material and preparation method thereof | UNIV BEIJING CHEMICAL | 2015-08-05 | — | — | CN | claimed |
| US-20140178480-A1 | SAFETY OF PSUEDOEPHEDRINE DRUG PRODUCTS | PISGAH LABORATORIES, INC. | 2014-06-26 | — | — | US | claimed |
| EP-1409579-A4 | CLARIFYING AGENT FORMULATIONS FOR THERMOPLASTICS EXHIBITING VERY HIGH NUCLEATION EFFICACY | MILLIKEN & CO (US) | 2005-03-09 | — | — | EP | claimed |
| EP-1409579-A1 | CLARIFYING AGENT FORMULATIONS FOR THERMOPLASTICS EXHIBITING VERY HIGH NUCLEATION EFFICACY | Milliken & Company (US) | 2004-04-21 | — | — | EP | claimed |
| WO-2003004554-A1 | CLARIFYING AGENT FORMULATIONS FOR THERMOPLASTICS EXHIBITING VERY HIGH NUCLEATION EFFICACY | MILLIKEN & COMPANY (US) | 2003-01-16 | — | — | WO | claimed |
| US-6121332-A | Monobenzylidene sorbitol gelling agent and method of use thereof | MILLIKEN & COMPANY (US) | 2000-09-19 | — | — | US | claimed |
| CN-117511034-A | Wear-resistant weather-resistant winding core pipe and preparation method thereof | 东莞市德永塑胶制品有限公司 | 2024-02-06 | — | — | CN | disclosed |
| CN-110591079-B | Preparation method of monofunctional nonlinear polyethylene glycol | 厦门赛诺邦格生物科技股份有限公司 | 2022-08-02 | — | — | CN | disclosed |
| CN-110305414-B | Polyolefin composition and process for preparing the same | 赣州蓝风科技有限公司 | 2021-11-26 | — | — | CN | disclosed |
| CN-110591079-A | Preparation method of monofunctional nonlinear polyethylene glycol | 厦门赛诺邦格生物科技股份有限公司 | 2019-12-20 | — | — | CN | disclosed |
| CN-104817830-B | A kind of aromatic polyester microcellular foam material and preparation method thereof | 北京化工大学 | 2016-08-24 | — | — | CN | disclosed |
| US-20030008953-A1 | Asymmetric dipolar multi-substituted alditol derivatives, methods of making thereof, and compositions and articles containing same | MILLIKEN & COMPANY | 2003-01-09 | — | — | US | disclosed |
| US-20020137953-A1 | Method of producing high yield alditol acetals with mineral acids and surfactants | MILLIKEN & COMPANY | 2002-09-26 | — | — | US | disclosed |
| US-6187842-B1 | REACTING SORBITOL OR XYLITOL WITH BENZALDEHYE IN PRESENCE OF ACID CATALYST | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2001-02-13 | — | — | US | disclosed |
| US-6121332-A | Monobenzylidene sorbitol gelling agent and method of use thereof | MILLIKEN & COMPANY (US) | 2000-09-19 | — | — | US | disclosed |
| US-6121332-A | Monobenzylidene sorbitol gelling agent and method of use thereof | MILLIKEN & COMPANY (US) | 2000-09-19 | — | — | US | disclosed |
| EP-0945452-A1 | SUGAR COMPOUNDS, GELLING AGENTS, GELLING AGENT COMPOSITIONS, PROCESSES FOR THE PREPARATION OF THEM, AND GEL COMPOSITIONS | NEW JAPAN CHEMICAL CO.,LTD. (JP) | 1999-09-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030008953-A1 | Asymmetric dipolar multi-substituted alditol derivatives, methods of making thereof, and compositions and articles containing same | DERA, SORD, ALDOA | SLC5A2 472/4885SLC5A1 756/4885LGALS9 3169/4885 |
| US-20140178480-A1 | SAFETY OF PSUEDOEPHEDRINE DRUG PRODUCTS | SORD, ABCB11, ABCB1 | SLC5A2 138/4885SLC5A1 75/4885LGALS9 2210/4885 |
| US-20020137953-A1 | Method of producing high yield alditol acetals with mineral acids and surfactants | SORD, ALDOA, DERA | SLC5A2 176/4885SLC5A1 371/4885LGALS9 3894/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.